4/18/2008

Ten major drugmakers, including Pfizer and AstraZeneca, have established an alliance to push for more relaxed government rules on the promotion of drugs for off-label uses. The FDA has issued draft guidelines that it says clarify the rules for disseminating information about unapproved uses.

Related Summaries